G.A. Dashyan (1), V.F. Semiglazov (1), E.E. Topuzov (2), V.G. Ivanov (1), V.V. Vorotnikov (1), I.A. Lalak (3), Zh.V. Bryantseva (2), M.V. Usungvan (2), A.I. Tseluyko (1)
BREAST CANCER AND PREGNANCY
|
№4 / 2014
|
O.V. Salafet 1, T.V. Chernovskaya 1 , L.P. Sheveleva 2 , A.V. Khorinko 3 , T.I. Prokopenko3, M.N. Nechayeva 4, O.N. Burdayeva 4 , M.P. Matrosova 5, N.V. Kovalenko 6 , I.A. Koroleva7, R.A. Ivanov 1
EFFICACY AND SAFETY OF EXTIMIA®, A NEW PEGYLATED FILGRASTIM: RESULTS OF OPEN COMPARATIVE PHASE II CLINICAL TRIAL IN PATIENTS WITH BREAST CANCER RECEIVING MYELOSUPPRESSIVE CHEMOTHERAPY
|
№17 / 2013
|